(Q47743666)

5 February 2018

title

The Italian SF-36 Health Survey: translation, validation and norming (English)

1 reference

5 February 2018

0 references

1

1 reference

5 February 2018

Paola Mosconi

series ordinal

2

1 reference

5 February 2018

publication date

1 November 1998

1 reference

5 February 2018

Journal of Clinical Epidemiology

published in

1 reference

5 February 2018

volume

51

1 reference

5 February 2018

issue

11

1 reference

5 February 2018

page(s)

1025-1036

1 reference

5 February 2018

Critical review of the international assessments of health-related quality of life

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

A therapy impact questionnaire for quality-of-life assessment in advanced cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

International Quality of Life Assessment (IQOLA) Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Evaluating translations of health status questionnaires. Methods from the IQOLA project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Survey of treatment of primary breast cancer in Italy. GIVIO (Interdisciplinary Group for Cancer Care Evaluation)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Methods for testing data quality, scaling assumptions, and reliability: the IQOLA Project approach. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach. International Quality of Life Assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

GISSI-3 study protocol on the effects of lisinopril, of nitrates, and of their association in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

From the development to the clinical application of a questionnaire on the quality of life in dialysis. The experience of the Italian Collaborative DIA-QOL (Dialysis-Quality of Life) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Criterion validity and reliability of the SF-36 in a population sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2898%2900094-8

7 January 2021

10.1016/S0895-4356(98)00094-8

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018